본문으로 바로가기
현재 위치:
Home
진료과
외과(유방암ㆍ갑상선암센터)
이장희
관심콘텐츠
프린트

의료진 소개

진료과 의료진
이장희 의사

이장희 교수


외과(유방암ㆍ갑상선암센터), 유방암센터 관심의료진 등록

전문 진료 분야

양성유방질환, 유방암, 일반검진

진료 일정

진료예약 간편 예약 고맙습니다

학력 및 경력사항

학력사항

  • 연세대학교 의과대학 박사
  • 연세대학교 의과대학 석사
  • 연세대학교 의과대학 학사

교육 및 연구경력

  • 2024-현재  | 이대목동병원 외과 임상조교수
  • 2022-2024  | 한림대학교 동탄성심병원 외과 조교수
  • 2021-2022  | 한림대학교 동탄성심병원 외과 임상조교수
  • 2019-2020  | 강남세브란스병원 유방외과 전임의
  • 2012-2016  | 세브란스병원 외과 전공의

기타 학술 관련 경력

  • 유럽종양외과학회(ESSO) 정회원
  • 유럽종양학회(ESMO) 정회원
  • 미국임상종양학회(ASCO) 정회원
  • 미국종양외과학회(SSO) 정회원
  • 대한종양외과학회 평생회원
  • 한국유방암학회 정회원
  • 대한외과학회 정회원

논문

  •  Omission of axillary surgery in cN0, postmenopausal ER-positive/HER2-negative breast cancer patients undergoing breast-conserving treatment.  Gland Surgery. 2024-09. 
  •  Micrometastases in axillary lymph nodes in breast cancer, post-neoadjuvant systemic therapy.  Breast Cancer Research. 2024-08. 
  •  Analysis of clinical factors and ultrasound features associated with COVID-19 vaccine-related axillary lymphadenopathy: A large group study.  Clinical Imaging. 2024-01. 
  •  BRCA1 mutation promotes sprouting angiogenesis in inflammatory cancer-associated fibroblast of triple-negative breast cancer.  Cell Death Discovery. 2024-01. 
  •  Prognostic impact of radiotherapy-induced-lymphopenia in patients treated with breast-conservative surgery.  Scientific Reports. 2023-09. 
  •  Ki-67, 21-Gene Recurrence Score, Endocrine Resistance, and Survival in Patients With Breast Cancer.  JAMA Network Open. 2023-08. 
  •  Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Early Standardized Uptake Value Reduction in Patients With Breast Cancer Receiving Neoadjuvant.  Journal of Breast Cancer. 2022-12. 
  •  Association of Body Mass Index With 21-Gene Recurrence Score Among Women With Estrogen Receptor–Positive, ERBB2–Negative Breast Cancer.  JAMA Network Open. 2022-05. 
  •  Primary endocrine resistance of ER+ breast cancer with ESR1 mutations interrogated by droplet digital PCR.  NPJ Breast Cancer. 2022-05. 
  •  The Impact of Post-Mastectomy Radiotherapy on Survival Outcomes in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy.  Cancers. 2021-12. 
  •  Diagnostic Accuracy of Nonmass Enhancement at Breast MRI in Predicting Tumor Involvement of the Nipple: A Prospective Study in a Single Institution.  Radiology. 2021-10. 
  •  Axillary response according to neoadjuvant single or dual human epidermal growth factor receptor 2 (HER2) blockade in clinically node-positive, HER2-positive breast cancer.  International Journal of Cancer. 2021-10. 
  •  Application of the 21-Gene Recurrence Score in Patients with Early HR-Positive/HER2-Negative Breast Cancer: Chemotherapy and Survival Rate According to Clinical Risk.  Cancers. 2021-08. 
  •  Relationship of the standard uptake value of 18F-FDG-PET-CT with tumor-infiltrating lymphocytes in breast tumors measuring ≥ 1 cm.  Scientific Reports. 2021-06. 
  •  Body mass index and absolute lymphocyte count predict disease-free survival in Korean breast cancer patients.  British Journal of Cancer. 2021-04. 
  •  Comparison of resection margin status after single or double radiopaque marker insertion for tumor localization in breast cancer patients receiving neoadjuvant chemotherapy.  Breast Cancer Research and Treatment. 2020-12. 
  •  Validation of Clinical Treatment Score post-5 years (CTS5) risk stratification in premenopausal breast cancer patients and Ki-67 labelling index.  Scientific Reports. 2020-10. 
  •  Comparison of complications according to incision types in nipple-sparing mastectomy and immediate reconstruction.  BREAST. 2020-10. 
  •  Significance of Non-Mass Enhancement in the Subareolar Region on Preoperative Breast Magnetic Resonance Imaging for Nipple-Sparing Mastectomy.  Clinical Breast Cancer. 2020-08. 
  •  Prognostic value of neutrophil-to-lymphocyte ratio in human epidermal growth factor receptor 2-negative breast cancer patients who received neoadjuvant .  Scientific Reports. 2020-08. 
  •  Do All Patients Require Prophylactic Drainage After Gastrectomy for Gastric Cancer? The Experience of a High-Volume Center.  Annals of Surgical Oncology. 2015-11. 
  •  Characteristics and Survival of Breast Cancer Patients with Multiple Synchronous or Metachronous Primary Cancers.  Yonsei Medical Journal. 2015-09.